00069-1318 RETACRIT - CanMED: NDC

Product NDC:

00069-1318

Brand Name:

RETACRIT

Generic Name:

epoetin alfa-epbx

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: EPOETIN

Strength: 10000.0

Unit: [iU]/mL

Packages:

Code: 00069-1318-04

Description: 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) > 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01)

Effective Date: Dec. 1, 2020

Discontinued:

Code: 00069-1318-10

Description: 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01)

Effective Date: Nov. 9, 2020

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Erythropoiesis-Stimulating Agent

Minor Class:

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox